Professionnels de santé

Grand public

Presse
Ensemble, améliorons la qualité en santé

Home > Professionnels de santé > Actes - Médicaments - Dispositifs médicaux > Médicaments

Transparency Committee Opinion

AZARGA

Date 18 February 2009
Pharmaceutical
formulation

AZARGA 10 mg/mL + 5 mg/mL, eye drops, suspension
Box containing 1 x 5 mL bottle (CIP: 391 266-4)

ATC code
  1. S01ED51
Active ingredient

brinzolamide

timolol
Requested by ALCON
Reason for request Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.

Documents

Tools

For more information

Contacts

Contact évaluation des médicaments

transparence@has-sante.fr


 

TAGS

Traitement médicamenteux
Haute Autorité de Santé - 2009